Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.

B.E. de Galan; S. Zoungas; J. Chalmers; C. Anderson; C. Dufouil; A. Pillai; M. Cooper; D.E. Grobbee; M. Hackett; P. Hamet; S.R. Heller; L. Lisheng; S. MacMahon; G. Mancia; B. Neal; C.Y. Pan; A. Patel; N. Poulter; F. Travert; M. Woodward

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.

Translated title of the contribution: Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.

B.E. de Galan
, S. Zoungas
, J. Chalmers
, C. Anderson
, C. Dufouil
, A. Pillai
, M. Cooper
, D.E. Grobbee
, M. Hackett
, P. Hamet
, S.R. Heller
, L. Lisheng
, S. MacMahon
, G. Mancia
, B. Neal
, C.Y. Pan
, A. Patel
, N. Poulter
, F. Travert
, M. Woodward

Julius Center, dept. Epidemiology & Health Economics

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.
Original language	Undefined/Unknown
Pages (from-to)	2328-2336
Number of pages	9
Journal	Diabetologia
Volume	52
Issue number	11
Publication status	Published - 2009

Cite this

de Galan, B. E., Zoungas, S., Chalmers, J., Anderson, C., Dufouil, C., Pillai, A., Cooper, M., Grobbee, D. E., Hackett, M., Hamet, P., Heller, S. R., Lisheng, L., MacMahon, S., Mancia, G., Neal, B., Pan, C. Y., Patel, A., Poulter, N., Travert, F., & Woodward, M. (2009). Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. Diabetologia, 52(11), 2328-2336.

@article{464d242f94f244e2b60540474de4f0de,

title = "Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.",

author = "\{de Galan\}, B.E. and S. Zoungas and J. Chalmers and C. Anderson and C. Dufouil and A. Pillai and M. Cooper and D.E. Grobbee and M. Hackett and P. Hamet and S.R. Heller and L. Lisheng and S. MacMahon and G. Mancia and B. Neal and C.Y. Pan and A. Patel and N. Poulter and F. Travert and M. Woodward",

year = "2009",

language = "Undefined/Unknown",

volume = "52",

pages = "2328--2336",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "11",

}

de Galan, BE, Zoungas, S, Chalmers, J, Anderson, C, Dufouil, C, Pillai, A, Cooper, M, Grobbee, DE, Hackett, M, Hamet, P, Heller, SR, Lisheng, L, MacMahon, S, Mancia, G, Neal, B, Pan, CY, Patel, A, Poulter, N, Travert, F & Woodward, M 2009, 'Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.', Diabetologia, vol. 52, no. 11, pp. 2328-2336.

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. / de Galan, B.E.; Zoungas, S.; Chalmers, J. et al.
In: Diabetologia, Vol. 52, No. 11, 2009, p. 2328-2336.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.

AU - de Galan, B.E.

AU - Zoungas, S.

AU - Chalmers, J.

AU - Anderson, C.

AU - Dufouil, C.

AU - Pillai, A.

AU - Cooper, M.

AU - Grobbee, D.E.

AU - Hackett, M.

AU - Hamet, P.

AU - Heller, S.R.

AU - Lisheng, L.

AU - MacMahon, S.

AU - Mancia, G.

AU - Neal, B.

AU - Pan, C.Y.

AU - Patel, A.

AU - Poulter, N.

AU - Travert, F.

AU - Woodward, M.

PY - 2009

Y1 - 2009

M3 - Article

SN - 0012-186X

VL - 52

SP - 2328

EP - 2336

JO - Diabetologia

JF - Diabetologia

IS - 11

ER -